Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 8OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vitamin D Deficiency 1Polycystic Ovary Syndrome 1Insulin Resistance 1

Interventions

Inositol 6follitropin alfa 4Glycoprotein Hormones, alpha Subunit 3follitropin beta 2Metformin 2Letrozole 2DLBS3233 2Clomiphene 2Chorionic Gonadotropin 2licogliflozin 1elagolix 1cetrorelix 1Urofollitropin 1Secretome 1Progesterone 1Oils 1Menotropins 1Leuprolide 1Lactalbumin 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Itraconazole 1Folic Acid 1Diosgenin 1Contraceptives, Oral 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Polycystic Ovary Syndrome × Cholecalciferol × Clear all
NCT02328404 2016-08-04

The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)

Hayat Pharmaceutical Co. PLC

Phase 3 Completed
60 enrolled 37 charts

Insulin Resistance, Polycystic Ovary Syndrome, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡